Sign in
4

Changes in Ownership

PepGen Inc. Filed Acc 0001127602-24-018155

SVP, Clinical Development sold 8,656 shares at an average $18.08 ($156,460)

  • SVP, Clinical Development acquired 8,656 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mellion Michelle L · SVP, Clinical Development

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-05 Exercise or conversion : show line 1 in the form 10b5-1 +7,245 $10.21 $73,971 7,245 D
2024-06-05 Sale : show line 2 in the form 10b5-1 −7,245 $18.09 $131,062 0 D
2024-06-06 Exercise or conversion : show line 3 in the form 10b5-1 +1,411 $10.21 $14,406 1,411 D
2024-06-06 Sale : show line 4 in the form 10b5-1 −1,411 $18.00 $25,398 0 D
Open-market sales · 8,656 sh · avg $18.08 · $156,460

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-06-05 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −7,245 92,755 D
2024-06-06 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −1,411 91,344 D
Loading xslF345X05/form4.xml…